We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$135M
AUM Growth
+$5.13M
Cap. Flow
+$2.88M
Cap. Flow %
2.13%
Top 10 Hldgs %
22.44%
Holding
185
New
26
Increased
50
Reduced
55
Closed
31

Top Buys

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$1.2M
2
COST icon
Costco
COST
+$1.15M
3
AMGN icon
Amgen
AMGN
+$1.07M
4
DY icon
Dycom Industries
DY
+$931K
5
LOW icon
Lowe's Companies
LOW
+$899K

Sector Composition

Rank Sector Weight
1 Industrials 21.57%
2 Healthcare 18.97%
3 Financials 18.11%
4 Consumer Staples 13.07%
5 Technology 10.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPS icon
26
United Parcel Service
UPS
$88.6B
$1.4M 1.04%
12,695
+300
+2% +$32.1K
CSX icon
27
CSX Corp
CSX
$93.4B
$1.4M 1.04%
77,019
-6,750
-8% -$116K
AVT icon
28
Avnet
AVT
$7.29B
$1.36M 1.01%
35,075
+1,500
+4% +$59.4K
COST icon
29
Costco
COST
$422B
$1.34M 0.99%
8,400
+6,700
+394% +$1.15M
MMM icon
30
3M
MMM
$90.9B
$1.33M 0.98%
7,645
-255
-3% -$42.6K
NVS icon
31
Novartis
NVS
$297B
$1.27M 0.94%
17,019
-670
-4% -$47.5K
NSC icon
32
Norfolk Southern
NSC
$75.4B
$1.25M 0.92%
+10,247
New +$1.2M
MSFT icon
33
Microsoft
MSFT
$3.45T
$1.24M 0.92%
17,954
+2,350
+15% +$161K
APD icon
34
Air Products & Chemicals
APD
$65.7B
$1.22M 0.9%
8,500
-450
-5% -$64K
BA icon
35
Boeing
BA
$171B
$1.21M 0.9%
6,125
-325
-5% -$60.5K
ABT icon
36
Abbott
ABT
$183B
$1.2M 0.88%
24,577
-300
-1% -$13.6K
GILD icon
37
Gilead Sciences
GILD
$162B
$1.16M 0.86%
16,440
-2,325
-12% -$155K
BEN icon
38
Franklin Resources
BEN
$17.6B
$1.16M 0.86%
25,900
+1,200
+5% +$51.3K
PYPL icon
39
PayPal
PYPL
$48.9B
$1.16M 0.86%
21,621
-8,629
-29% -$424K
MS icon
40
Morgan Stanley
MS
$331B
$1.13M 0.84%
25,414
+5,250
+26% +$226K
URI icon
41
United Rentals
URI
$67.2B
$1.13M 0.84%
10,045
+1,850
+23% +$207K
RF icon
42
Regions Financial
RF
$26.4B
$1.13M 0.83%
77,065
+14,700
+24% +$207K
EMR icon
43
Emerson Electric
EMR
$83.9B
$1.09M 0.81%
18,345
-350
-2% -$20.8K
ALK icon
44
Alaska Air
ALK
$5.29B
$1.09M 0.81%
12,125
+8,700
+254% +$763K
TRN icon
45
Trinity Industries
TRN
$2.49B
$1.09M 0.81%
53,914
+23,335
+76% +$448K
AGN
46
DELISTED
Allergan plc
AGN
$1.08M 0.8%
4,450
+2,175
+96% +$511K
J icon
47
Jacobs Solutions
J
$15.9B
$1.07M 0.79%
23,877
+1,209
+5% +$53.8K
PPG icon
48
PPG Industries
PPG
$24.6B
$1.07M 0.79%
9,725
-350
-3% -$37.9K
BRK.B icon
49
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.04M 0.77%
6,150
-100
-2% -$16.6K
SNA icon
50
Snap-on
SNA
$21.2B
$1.01M 0.75%
6,411
+1,850
+41% +$303K

Similar funds

New England Research & Management's Q2 2017 Portfolio in Review

As of Q2 2017, New England Research & Management held 185 positions worth $135M, up 3.9% from $130M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q2 2017 filing shows 26 new, 50 increased, 55 reduced and 31 closed positions. Its largest new stake was Norfolk Southern: 10,247 shares worth $1.25M. The largest sale was Toll Brothers, an estimated $1.28M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q2 2017 buy was Norfolk Southern: 10,247 shares worth $1.25M.
  • New England Research & Management added most to Costco in Q2 2017, an estimated $1.15M increase.
  • New England Research & Management's biggest Q2 2017 reduction was CVS Health, cutting an estimated $910K.
  • New England Research & Management fully exited Toll Brothers in Q2 2017, selling an estimated $1.28M.
  • New England Research & Management's ten largest holdings make up 22% of its $135M portfolio in Q2 2017.
  • New England Research & Management opened 26 new positions and closed 31 in Q2 2017.
  • New England Research & Management's portfolio value rose 3.9% quarter-over-quarter to $135M.

Based on New England Research & Management's 13F filing for Q2 2017, filed 11 Jul 2017.